<!DOCTYPE html>
<html>
<head>
    <title>PressReader - The Straits Times: 2020-08-08 - Medis&#xAD;ave can be used for clin&#xAD;i&#xAD;cally and cost-ef&#xAD;fec&#xAD;tive HPV vac&#xAD;cines</title>
    <meta name="description" content="">
    <meta content="magazines, newspapers, digital news, reading, news, breaking news, newspaper online" name="keywords">
    <meta name="Robots" content="NOARCHIVE,NOODP">
    <meta charset="UTF-8">
    <meta http-equiv="Content-type" content="text/html; charset=utf-8" />
    <meta name="viewport" content="width=device-width, initial-scale=1" />
    
    <link rel="canonical" href="/singapore/the-straits-times/20200808/282252372875804" />


    <style>
        li {
            margin: 1em 0;
        }
        img {
            max-width: 100%;
        }
        p, h1, h2, h3 {
            max-width: 100%;
        }
    </style>
</head>
<body>
    <div>
        

<article>
    <h1>Medis&#xAD;ave can be used for clin&#xAD;i&#xAD;cally and cost-ef&#xAD;fec&#xAD;tive HPV vac&#xAD;cines</h1>
    <h2></h2>
    <section>
        <a href="/singapore/the-straits-times/textview" title="The Straits Times">The Straits Times</a>
        - <a href="/singapore/the-straits-times/20200808/textview" title="The Straits Times - 2020-08-08"><time>2020-08-08</time></a>
        - <span>FORUM</span>
        - <span role="byline">Cham Dao Song Direc&#xAD;tor, Fi&#xAD;nance Pol&#xAD;icy Min&#xAD;istry of Health</span>
    </section>

    <p>We thank Ms Lin Hui Jing for her let­ter (Re­view Medis­ave use for HPV vac­cines, Aug 1).</p>
    <p>To­day, Medis­ave is ex­tended to vac­cines that are rec­om­mended un­der the na­tional im­mu­ni­sa­tion sched­ules. These im­mu­ni­sa­tion sched­ules are reg­u­larly re­viewed by the Min­istry of Health (MOH) in con­sul­ta­tion with the Ex­pert Com­mit­tee on Im­mu­ni­sa­tion, tak­ing ref­er­ence from in­ter­na­tional best prac­tices, emerg­ing clin­i­cal data, and cost-ef­fec­tive­ness eval­u­a­tions.</p>
    <p>There are cur­rently three hu­man pa­pil­lo­mavirus (HPV) vac­cines reg­is­tered in Sin­ga­pore – Cer­varix, Gar­dasil, and Gar­dasil 9. Cer­varix and Gar­dasil are cur­rently rec­om­mended un­der the na­tional im­mu­ni­sa­tion sched­ules for use in fe­males be­tween the ages of nine and 26 years.</p>
    <p>Cer­varix and Gar­dasil pro­tect against HPV in­fec­tion from two of the most com­mon cer­vi­cal cancer-caus­ing HPV types (16 and 18), which ac­count for about 70 per cent of cer­vi­cal cancer cases, and have been shown to be both clin­i­cally and cost-ef­fec­tive in the lo­cal set­ting.</p>
    <p>Cur­rently, at the price pro­posed by the man­u­fac­turer, Gar­dasil 9 is not cost-ef­fec­tive com­pared with al­ter­na­tive HPV vac­cines and has not been in­cluded un­der the na­tional im­mu­ni­sa­tion sched­ules. It is why Gar­dasil 9 is not el­i­gi­ble for Medis­ave use.</p>
    <p>MOH will con­tinue to en­gage the man­u­fac­turer to achieve a rea­son­able price for in­clu­sion on the sched­ules.</p>


</article>

<section>
    <h3><a href="/catalog/language/english">Newspapers in English</a></h3>
    <h3><a href="/catalog/country/singapore">Newspapers from Singapore</a></h3>
</section>

    </div>
    
    <p><a href="http://www.pressreader.com">© PressReader. All rights reserved.</a></p>

        <script>
            (function (i, s, o, g, r, a, m) {
                i['GoogleAnalyticsObject'] = r; i[r] = i[r] || function () {
                    (i[r].q = i[r].q || []).push(arguments);
                }, i[r].l = 1 * new Date();
                a = s.createElement(o), m = s.getElementsByTagName(o)[0]; a.async = 1; a.src = g;
                m.parentNode.insertBefore(a, m);
            })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
        </script>
        <script>
            ga('create', 'UA-44408245-1');
            ga('send', 'pageView');
        </script>
</body>
</html>
